This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
International Agency for Research on Cancer: World Health Organization. Cancer today. Accessed March 3. 2022, 3:2022.Search in Google Scholar
Dyba T, Randi G, Bray F, et al.: The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers. Eur J Cancer. 2021, 157:308-347. 10.1016/j.ejca.2021.07.039Search in Google Scholar
Suster DI, Mino-Kenudson M: Molecular Pathology of Primary Non-small Cell Lung Cancer. Arch Med Res. 2020, 51:784-798. 10.1016/j.arcmed.2020.08.004. Epub 2020 Aug 29Search in Google Scholar
Degeling K, Baxter NN, Emery J, et al.: An inverse stage-shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the SARS-COV2 pandemic. Asia Pac J Clin Oncol. 2021, 17:359-367. 10.1111/ajco.13505. Epub 2021 Feb 10Search in Google Scholar
Wang Y, Zou S, Zhao Z, et al.: New insights into small-cell lung cancer development and therapy. Cell Biol Int. 2020, 44:1564-1576. 10.1002/cbin.11359. Epub 2020 Apr 18Search in Google Scholar
Patt D, Gordan L, Diaz M, et al.: Impact of SARS-COV2 on Cancer Care: How the Pandemic Is Delaying Cancer Diagnosis and Treatment for American Seniors. JCO Clin Cancer Inform. 2020, 4:1059-1071.10.1200/CCI.20.00134Search in Google Scholar
Purushotham A, Roberts G, Haire K, et al.: The impact of national non-pharmaceutical interventions ('lockdowns') on the presentation of cancer patients. Ecancermedicalscience. 2021, 3:1180. 10.3332/ecancer.2021.1180Search in Google Scholar
Gurney JK, Dunn A, Liu M, et al.: The impact of COVID-19 on lung cancer detection, diagnosis, and treatment for Māori in Aotearoa New Zealand. N Z Med J. 2022 Jun. 10:23-43.Search in Google Scholar
Werner RS, Lörtscher A, Kirschner MB, et al.: Surgical management of lung cancer during the SARS-COV2 pandemic - a narrative review and single-centre report. Swiss Med Wkly. 2022, 7:30109. 10.4414/smw.2022.w30109Search in Google Scholar
Vardhanabhuti V, Ng KS: Differential Impact of SARS-COV2 on Cancer Diagnostic Services Based on Body Regions: A Public Facility-Based Study in Hong Kong. Int J Radiat Oncol Biol Phys. 2021, 1:331-336.10.1016/j.ijrobp.2021.05.010Search in Google Scholar
Serra Mitjà P, Àvila M, García-Olivé I: Impact of the COVID-19 pandemic on lung cancer diagnosis and treatment. Med Clin (Barc. 2022, 11:138-139. 10.1016/j.medcle.2021.07.009Search in Google Scholar
Riera R, Bagattini ÂM, Pacheco RL, et al.: Delays and Disruptions in Cancer Health Care Due to SARS-COV2. Pandemic:2021-7. 10.1200/GO.20.00639Search in Google Scholar
Kasymjanova G, Anwar A, Cohen V: The Impact of SARS-COV2 on the Diagnosis and Treatment of Lung Cancer at a Canadian Academic Center: A Retrospective Chart Review. Curr Oncol. 202120, 28:4247-4255.10. 3390/curroncol28060360Search in Google Scholar
Cantini L, Mentrasti G, Russo GL, et al.: Evaluation of COVID-19 impact on DELAYing diagnostic therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario. ESMO Open. 2022, 7:100406-10. 10.1016/j.esmoop.2022.100406Search in Google Scholar
Park JY, Lee YJ, Kim T, et al.: Collateral effects of the coronavirus disease 2019 pandemic on lung cancer diagnosis in Korea. BMC Cancer. 202029, 20:1040. 10.1186/s12885-020-07544-3Search in Google Scholar
Terashima T, Tsutsumi A, Iwami E, et al.: Delayed visit and treatment of lung cancer during the coronavirus disease 2019 pandemic in Japan: a retrospective study. J Int Med Res. 2022, 50:3000605221097375. 10.1177/03000605221097375Search in Google Scholar
Zhang Y, Li J, Li ZK, et al.: Impact of Coronavirus Disease 2019 on Clinical Characteristics in Patients With Lung Cancer: A Large Single-Centre Retrospective Study. Front Oncol. 2021, 16:693002. 10.3389/fonc.2021.693002Search in Google Scholar
Piwkowski C, Gabryel P, Orłowski TM, et al.: The impact of the SARS-COV2 pandemic on surgical treatment of lung cancer. Pol Arch Intern Med. 2022, 28:16191. 10.20452/pamw.16191. Epub 2022 Jan 13Search in Google Scholar
Fu R, Wu L, Zhang C, et al.: Real-World Scenario of Patients With Lung Cancer Amid the Coronavirus Disease 2019 Pandemic in the People's Republic of China. JTO Clin Res Rep. 2020, 1:100053. 10.1016/j.jtocrr.2020.100053. Epub 2020 May 20Search in Google Scholar
Brims FJH, Kumarasamy C, Nash J, et al.: Hospital-based multidisciplinary lung cancer care in Australia: a survey of the landscape in 2021. BMJ Open Respir Res. 2022, 9:001157. 10.1136/bmjresp-2021-001157Search in Google Scholar
Vlăsceanu S, Bobocea A, Petreanu CA, Bădărău IA, Moldovan H, Gheorghi ă D, Antoniac IV, Mirea L, Diaconu CC, Savu C. Pulmonary Crohn's Disease or Crohn's Disease with Lung Sarcoidosis? A Case Report and Literature Review. Healthcare (Basel). 2022 Nov 11;10(11):2267. doi: 10.3390/healthcare10112267. PMID: 36421591; PMCID: PMC9690086.Open DOISearch in Google Scholar
Bolca C, Has A, Bobocea A, Afetelor A, Stoica R, Strambu I, Stoicescu I, Magheran E, Balescu I, Bacalbasa N, Gherghiceanu F, Furtunescu F, Radavoi D, Diaconu C, Paleru C, Cordos I. A Rare Thymic Tumor -Lipofibroadenoma - Always a Postoperative Surprise. In Vivo. 2021 Nov-Dec;35(6):3623-3626. doi: 10.21873/invivo.12668. PMID: 34697204; PMCID: PMC8627725..Open DOISearch in Google Scholar
Adjuvant chemotherapy for radically resected non-small cell lung cancer - A retrospective analysis of 311 consecutively treated patients Dediu, M; Horvat, T; (...); Savu, C Jan 2005 LUNG CANCER 47 (1), pp.93-101Search in Google Scholar
